An 84-year-old male diagnosed with primary myelofibrosis based on WHO grade 2-3 fibrosis Figure 1 and the presence of the JAK2-V617F mutation was treated with supportive care. During 2 years of follow-up, his hemoglobin level was maintained at approximately 6.5 mmol/L and platelet count declined from 128x109/L at presentation to 50x109/L. White blood cells did not exceed 12.0x109/L, while the fraction of blast cells increased to 10%. Elevated levels of teardrop cells were observed and the nucleated red blood cell count gradually increased from non-detectable to 2.4x1012/L. Recent peripheral blood smears showed bi- and tri-nucleated red blood cells, and even more notably, erythroid precursors with internuclear chromatin and cytoplasmic bridging Figures 2 and 3. In concurrence with laboratory findings, physical examination revealed progressive splenomegaly (8 cm palpable below the rib margin) and weight loss. Erythroid precursors with internuclear bridging in a blood smear is a rare morphological finding and is considered a diagnostic morphologic feature in patients with congenital dyserythropoietic anemia type I and a morphological manifestation of dyserythropoiesis in patients with myelodysplastic syndrome [1, 2] In patients with myeloproliferative neoplasms, erythroid precursors’ internuclear bridging may indicate the transition to a more aggressive phase.
Figure 1. Bone marrow biopsy showing marked increase in reticulin fibers, especially in the areas of megakaryocyte clustering (Gomori, 10x).

Figure 2. Blood smear demonstrating teardrop cells, erythroid precursor with internuclear bridging, and one blast cell (May-Grünwald-Giemsa, 50x).

Figure 3. Blood smear demonstrating erythroid precursor with internuclear and cytoplasmic bridging (May-Grünwald-Giemsa, 100x).

Footnotes
Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.
References
- 1.Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica. 2012;97:1786–1794. doi: 10.3324/haematol.2012.072207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Head DR, Kopecky K, Bennett JM, Grenier K, Morrison FS, Miller KB, Grever MR. Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study. Cancer. 1989;64:2199–2202. doi: 10.1002/1097-0142(19891201)64:11<2199::aid-cncr2820641102>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
